Analysts predict that Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) will announce earnings per share of $0.17 for the current quarter, Zacks reports. Ten analysts have made estimates for Allscripts Healthcare Solutions’ earnings, with the highest EPS estimate coming in at $0.20 and the lowest estimate coming in at $0.13. Allscripts Healthcare Solutions reported earnings per share of $0.13 during the same quarter last year, which would suggest a positive year-over-year growth rate of 30.8%. The business is expected to report its next earnings report on Thursday, May 3rd.
According to Zacks, analysts expect that Allscripts Healthcare Solutions will report full-year earnings of $0.77 per share for the current year, with EPS estimates ranging from $0.72 to $0.80. For the next fiscal year, analysts anticipate that the company will report earnings of $0.89 per share, with EPS estimates ranging from $0.83 to $0.97. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Allscripts Healthcare Solutions.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, February 15th. The software maker reported $0.18 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. The business had revenue of $547.00 million for the quarter, compared to analysts’ expectations of $524.05 million. Allscripts Healthcare Solutions had a positive return on equity of 7.36% and a negative net margin of 10.88%. The business’s revenue was up 27.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.14 EPS.
Allscripts Healthcare Solutions (NASDAQ MDRX) traded up $0.13 during trading on Friday, reaching $13.92. The company’s stock had a trading volume of 1,674,800 shares, compared to its average volume of 1,947,239. The company has a debt-to-equity ratio of 1.33, a quick ratio of 0.98 and a current ratio of 0.97. The company has a market cap of $2,550.00, a PE ratio of -12.00, a price-to-earnings-growth ratio of 2.03 and a beta of 1.18. Allscripts Healthcare Solutions has a fifty-two week low of $11.25 and a fifty-two week high of $16.13.
In related news, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, December 14th. The stock was sold at an average price of $14.35, for a total value of $71,750.00. Following the transaction, the executive vice president now directly owns 191,607 shares of the company’s stock, valued at approximately $2,749,560.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP James Hewitt sold 36,796 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $14.11, for a total value of $519,191.56. Following the completion of the transaction, the senior vice president now directly owns 181,766 shares in the company, valued at $2,564,718.26. The disclosure for this sale can be found here. Insiders sold a total of 56,796 shares of company stock worth $804,842 over the last ninety days. 0.91% of the stock is currently owned by insiders.
A number of hedge funds have recently added to or reduced their stakes in MDRX. Zeke Capital Advisors LLC bought a new position in Allscripts Healthcare Solutions in the 4th quarter valued at approximately $165,000. Avestar Capital LLC bought a new position in Allscripts Healthcare Solutions in the 4th quarter valued at approximately $173,000. Sheaff Brock Investment Advisors LLC bought a new position in Allscripts Healthcare Solutions in the 3rd quarter valued at approximately $174,000. Quantitative Systematic Strategies LLC bought a new position in Allscripts Healthcare Solutions in the 4th quarter valued at approximately $182,000. Finally, Crossmark Global Holdings Inc. bought a new position in Allscripts Healthcare Solutions in the 3rd quarter valued at approximately $187,000.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.